Occult renal impairment is common in patients with peripheral vascular disease and normal serum creatinine

S T Rashid1, M Salman, S Agarwal

  • 1University Department of Vascular Surgery, Royal Free Hospital, London, UK. trashid@medsch.ucl.ac.uk

Insights

Many peripheral vascular disease (PVD) patients with normal serum creatinine have impaired renal function, as measured by creatinine clearance (CrCl). CrCl assessment is crucial for PVD patients, especially those over 75, with heart disease, or elevated serum creatinine.

Area of Science:

  • Nephrology
  • Vascular Surgery
  • Cardiology

Background:

  • Peripheral vascular disease (PVD) and related interventions are increasing.
  • Renal function is a critical predictor of mortality and bypass graft failure in PVD patients.
  • Serum creatinine (SCr) can underestimate renal impairment; creatinine clearance (CrCl) is a more sensitive measure.

Purpose of the Study:

  • To investigate the incidence of renal impairment, defined by CrCl, in PVD patients presenting with normal SCr.
  • To compare CrCl in PVD patients with a control group.

Main Methods:

  • Assessed CrCl using 24-hour urine collection and the Cockcroft-Gault formula in PVD patients with normal SCr undergoing angiography.
  • Collected blood tests and patient history.
  • Compared CrCl in PVD patients with age- and sex-matched controls with similar SCr.

Main Results:

  • 86% of PVD patients with normal SCr had subnormal CrCl (<100 ml/min), and 65% had CrCl <60 ml/min.
  • PVD patients had significantly worse CrCl than controls (median 52 vs. 80 ml/min).
  • Factors associated with reduced CrCl included age ≥75, SCr ≥85 µmol/l, and history of coronary heart disease; statin use was associated with improved CrCl.

Conclusions:

  • A majority of PVD patients with normal SCr exhibit occult renal impairment detectable by CrCl.
  • Vascular surgeons should incorporate CrCl assessment into pre-operative evaluations for PVD patients, particularly those with risk factors.
  • Early nephrology referral for PVD patients with impaired CrCl is recommended; statin use may offer renal protection.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...